Epidermal growth factor, growth differentiation factor-15, and survivin as novel biocompatibility markers in children on chronic dialysis

Biomarkers

Volumn 21, Issue 8, 2016, Pages 752-756

  Bargenda, Agnieszka ^a   Musiał, Kinga ^a   Zwolińska, Danuta ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Apoptosis; chronic kidney disease; growth factors

Indexed keywords

CHOLESTEROL; EPIDERMAL GROWTH FACTOR; GROWTH DIFFERENTIATION FACTOR 15; HEAT SHOCK PROTEIN 27; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERUM ALBUMIN; SURVIVIN; TRIACYLGLYCEROL;

ALBUMIN BLOOD LEVEL; APOPTOSIS; ARTICLE; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIMIT OF DETECTION; MALE; PERITONEAL DIALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84976320975     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/1354750X.2016.1201534     Document Type: Article

References (23)

1. G.Ambrosini, C.Adida, D.C.Altieri (1997). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–21.
2. M.C.C.Andreoli, M.A.Dalboni, R.Watanabe,. (2007). Impact of dialyzer membrane on apoptosis and function of polymorphonuclear cells and cytokine synthesis by peripheral blood mononuclear cells in hemodialysis patients. Artif Organs 31:887–910.
3. M.R.Bootcov, A.R.Bauskin, S.M.Valenzuela,. (1997). MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 94:11514–19.
4. S.N.Breit, J.J.Carrero, V.W.Tsai,. (2012). Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease. Nephrol Dial Transplant 27:70–5.
5. P.Cassis, S.Solini, N.Azzollini,. (2014). An unanticipated role for survivin in organ transplant damage. Am J Transplant 14:1046–60.
6. J.Chen, J.K.Chen, E.M.Conway, R.C.Harris (2013). Survivin mediates renal proximal tubule recovery from AKI. J Am Soc Nephrol 24:2023–33.
7. J.Corre, B.Hebraud, P.Bourin (2013). Concise review:growth differentiation factor 15 in pathology:a clinical role? Stem Cells Transl Med 2:946–52.
8. L.B.Daniels, P.Clopton, G.A.Laughlin,. (2011). Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults:the Rancho Bernardo Study. Circulation 123:2101–10.
9. R.J.Faull, J.M.Stanley, S.Fraser,. (2001). HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migration. Kidney Int 59:614–24.
10. G.Grandaliano, L.Gesualdo, F.Bartoli,. (2000). MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney Int 58:182–92.
11. I.Iwamoto, A.Imada (1992). Effects of growth factors on proliferation of cultured human peritoneal mesothelial cells. Nihon Jinzo Gakkai Shi 34:1201–8.
12. H.Johnen, S.Lin, T.Kuffner,. (2007). Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat Med 13:1333–40.
13. J.H.Ku, G.Godoy, G.E.Amiel, S.P.Lerner (2012). Urine survivin as a diagnostic biomarker for bladder cancer:a systematic review. BJU Int 110:630–6.
14. E.Lurbe, R.Cifkova, J.K.Cruickshank,. (2009). Management of high blood pressure in children and adolescents:recommendations of the European Society of Hypertension. J Hypertens 27:1719–42.
15. K.Musiał, A.Bargenda, D.Zwolińska (2015). Urine survivin, E-cadherin and matrix metalloproteinases as novel biomarkers in children with chronic kidney disease. Biomarkers 20:177–82.
16. J.Sertic, J.Slavicek, N.Bozina,. (2007). Cytokines and growth factors in mostly atherosclerotic patients on hemodialysis determined by biochip array technology. Clin Chem Lab Med 45:1347–52.
17. M.Stangou, E.Alexopoulos, A.Papagianni,. (2009). Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy. Nephrology (Carlton) 14:613–20.
18. J.Tang, N.Liu, S.Zhuang (2013). Role of epidermal growth factor receptor in acute and chronic kidney injury. Kidney Int 83:804–10.
19. D.D.Torres, M.Rossini, C.Manno,. (2008). The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. Kidney Int 73:327–33.
20. J.Waligórska-Stachura, A.Jankowska, R.Waśko,. (2012). Survivin-prognostic tumor biomarker in human neoplasms-review. Ginekol Pol 83:537–40.
21. F.E.Wiklund, A.M.Bennet, P.K.Magnusson,. (2010). Macrophage inhibitory cytokine-1 (MIC-1/GDF15):a new marker of all-cause mortality. Aging Cell 9:1057–64.
22. X.Xu, Z.Li, W.Gao (2011). Growth differentiation factor 15 in cardiovascular diseases:from bench to bedside. Biomarkers 16:466–75.
23. H.Yilmaz, H.T.Çelik, O.M.Gurel,. (2015). Increased serum levels of GDF-15 associated with mortality and subclinical atherosclerosis in patients on maintenance hemodialysis. Herz 40:305–12.